Bionano Genomics, Inc.
BNGO
$4.00
$0.000.00%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 30.78M | 33.33M | 36.58M | 37.47M | 36.12M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 30.78M | 33.33M | 36.58M | 37.47M | 36.12M |
| Cost of Revenue | 30.40M | 33.93M | 25.98M | 27.15M | 26.55M |
| Gross Profit | 380.00K | -599.00K | 10.60M | 10.32M | 9.57M |
| SG&A Expenses | 41.61M | 59.69M | 75.12M | 90.50M | 95.96M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 96.80M | 126.65M | 143.20M | 167.53M | 176.54M |
| Operating Income | -66.03M | -93.32M | -106.62M | -130.06M | -140.43M |
| Income Before Tax | -111.98M | -135.79M | -204.09M | -226.77M | -232.43M |
| Income Tax Expenses | 33.00K | -4.00K | 11.00K | 18.00K | 62.00K |
| Earnings from Continuing Operations | -112.02 | -135.78 | -204.10 | -226.79 | -232.49 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -112.02M | -135.78M | -204.10M | -226.79M | -232.49M |
| EBIT | -66.03M | -93.32M | -106.62M | -130.06M | -140.43M |
| EBITDA | -52.00M | -78.10M | -93.40M | -116.53M | -126.72M |
| EPS Basic | -93.29 | -147.20 | -309.25 | -368.97 | -406.96 |
| Normalized Basic EPS | -41.90 | -84.16 | -111.90 | -147.67 | -173.55 |
| EPS Diluted | -93.54 | -147.45 | -309.50 | -369.22 | -407.02 |
| Normalized Diluted EPS | -41.90 | -84.16 | -111.90 | -147.67 | -173.55 |
| Average Basic Shares Outstanding | 5.08M | 4.10M | 3.25M | 2.65M | 2.28M |
| Average Diluted Shares Outstanding | 5.08M | 4.10M | 3.25M | 2.65M | 2.28M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |